Medications

US company withdraws ALS drug after it fails in trial

Amylyx Pharmaceuticals announced Thursday it was withdrawing its approved treatment against the deadly neurodegenerative disease ALS after clinical data found no evidence the drug worked.

Neuroscience

Optimizing chronic subdural hematoma treatment

Chronic subdural hematoma (CSDH) is a neurological condition where blood clots between the brain's surface and its outer covering, causing symptoms like headaches and weakness. Alarmingly, its global incidence and recurrence ...

Genetics

Colorectal cancer gene implicated in broad range of solid tumors

A gene associated with colorectal cancer appears to also play a role in the development of other solid tumors, according to a study of over 350,000 patient biopsy samples conducted by researchers at the Johns Hopkins Kimmel ...

page 1 from 40